Viking Therapeutics, Inc. - Common Stock (VKTX)
CUSIP: 92686J106
Q1 2017 13F Holders as of 31 Mar 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 113,177,462
- Total 13F shares
- 769,601
- Share change
- +149,913
- Total reported value
- $1,124,000
- Price per share
- $1.46
- Number of holders
- 10
- Value change
- +$226,915
- Number of buys
- 6
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92686J106:
Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
0.24%
|
270,222
|
$322,000 | — | 31 Dec 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
163,200
|
$194,000 | — | 31 Dec 2016 | |
| SHEPHERD KAPLAN KROCHUK, LLC |
13F
|
Company |
0.08%
|
94,978
|
$113,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
31,264
|
$37,000 | — | 31 Dec 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
29,239
|
$35,000 | — | 31 Dec 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
16,962
|
$20,000 | — | 31 Dec 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
15,639
|
$19,000 | — | 31 Dec 2016 | |
| Acrospire Investment Management LLC |
13F
|
Company |
0.01%
|
10,766
|
$13,000 | — | 31 Dec 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
1,807
|
$2,000 | — | 31 Dec 2016 | |
| REILLY FINANCIAL ADVISORS, LLC |
13F
|
Company |
0%
|
1,250
|
$1,000 | — | 31 Dec 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
703
|
$1,000 | — | 31 Dec 2016 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
500
|
$1,000 | — | 31 Dec 2016 |
Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q1 2017
As of 31 Mar 2017,
Viking Therapeutics, Inc. - Common Stock (VKTX) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
769,601 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GRT CAPITAL PARTNERS L.L.C., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Acrospire Investment Management LLC, UBS Group AG, MANUFACTURERS LIFE INSURANCE COMPANY, THE, REILLY FINANCIAL ADVISORS, LLC, and BlackRock Inc..
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
11
Q1 2017 holders
10
Holder diff
-1
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.